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Abstract: 
Microtubule-associated proteins (MAPs) were initially discovered as proteins that bind and 
stabilise microtubules. Today, an ever-growing number of MAPs reveals a more complex 
picture of these proteins as organisers of the microtubule cytoskeleton with a large variety of 
functions. MAPs enable microtubules to participate in a plethora of cellular processes such as 
the assembly of mitotic and meiotic spindles, neuronal development, or the formation of the 
ciliary axoneme. While some subgroups of MAPs have been exhaustively characterised, a 
strikingly large number of MAPs remains barely characterized, other than their interactions 
with microtubules. Here, we provide a comprehensive view on the currently known MAPs in 
mammals. We discuss their molecular mechanisms and functions, as well as their 
physiological role and links to pathologies.  
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Defining Structural MAPs.  
Microtubules are a major component of the eukaryotic cytoskeleton that are uniformly 
assembled from conserved a/b-tubulin heterodimers. Microtubules play important roles in 
virtually every cellular process, such as cell division, cell motility, intracellular organization 
and trafficking of organelles. To fulfil these divergent functions, microtubules assemble into 
distinct arrays that are characterized by a defined architecture and dynamics. Formation of 
these assemblies requires specialized proteins that interact with microtubules – the 
microtubule-associated proteins (MAPs). Based on their mode of action, MAPs can be 
classified into (a) motile MAPs or motor proteins that generate forces and movement [1, 2], 
(b) enzymes that break or depolymerize microtubules [3], (c) microtubule nucleators [4], (d) 
end-binding proteins that specifically associate with plus- or minus-ends of microtubules [5], 
and (e) the so-called structural MAPs. While the first four categories (a-d) of MAPs are 
clearly defined by their functions, the latter category (e) is a rather vaguely defined, 
heterogenous group of proteins that bind, and thus stabilize microtubules, but no systematic 
view on their functions has so far emerged. Here, we discuss the current understanding of the 
mechanisms and functions of those structural MAPs. Our review focusses on mammalian 
MAPs, and we refrain from discussing the extensively-studied posttranslational regulation of 
MAPs, which has been reviewed in detail elsewhere [6, 7]. 
 
Discovery of microtubule-associated proteins  
Early efforts to purify tubulin from brain extracts using cycles of assembly-disassembly led to 
the identification of the first MAPs, MAP1 and MAP2, as higher-molecular components of 
microtubule assemblies [8, 9]. At the same time, a different biochemical purification 
procedure led to the discovery of tau, another protein factor essential for microtubule 
assembly [10-12]. In contrast to MAP1 and MAP2, tau protein was of lower molecular 
weight, strikingly correlated with the impact of those proteins on microtubule assemblies: 
while MAP2 formed long projections at the microtubule surface that increased the distance 
between single microtubules, microtubules decorated with the smaller tau protein were 
packed much denser [13]. It thus appeared that MAPs have the ability to control the structure 
of microtubule assemblies, hence referred to as ‘structural MAPs’.  
The development of a method to purify tubulin from HeLa cells was instrumental in the 
discovery of two novel, non-neuronal, MAPs of 210 kDa and 125 kDa [14]. The 210-kDa 
MAP was considered a bona fide MAP based on its similarity to previously characterized 
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MAPs [15], and was named MAP4 [16]. The 125-kDa protein corresponded to the later-
described MAP7 [17, 18].  
All MAPs had to this point been identified by their capacity to promote the assembly of 
tubulin into microtubules. However, a considerable share of microtubules never disassembles 
when tubulin is purified from brain tissue. A closer biochemical characterization of these 
cold-stable microtubules led to the discovery of the protein STOP (stable tubule only peptide) 
as a factor that confers cold-stability to microtubules [19, 20]. As purified STOP protein 
behaves like a MAP [21], it was later named MAP6. 
Apart from those initially characterized major MAPs, several minor proteins were detected in 
fractions of polymerized tubulin, which all could potentially be MAPs as well [22, 23]. 
Monoclonal antibody technologies bolstered the purification of some of these potential 
MAPs, for instance MAP3 [24] and MAP5 [25]. Strikingly, another protein, MAP1C, turned 
out to be the retrograde motor protein, cytoplasmic dynein [26, 27].  
By the end of the 1980s, advances in molecular cloning clarified the identity of many of the 
MAPs that were so far only biochemically characterized. MAP1 and MAP5 were found to be 
encoded by distinct genes, but as they are highly similar proteins, were renamed MAP1A and 
MAP1B [28]. In contrast, different isoforms of MAP2, referred to as MAP2A, 2B and 2C, 
originate from alternative splicing of the same transcript [29, 30]. Surprisingly, MAP3 and 
MAP4, thought to be two distinct proteins based on immunological assays, appeared to be 
identical gene products, and are now referred to as MAP4 [31]. The cloning of tau protein 
revealed that a single gene gives rise to six distinct splice isoforms [32, 33]. The differential 
splicing of tau protein received a particularly broad attention, given that tau is the main 
component of paired helical filaments (PHFs) – one of the pathological hallmarks of 
Alzheimer’s disease [34].  
In the 1990s, annotated genome and cDNA sequences allowed the bioinformatic identification 
of novel MAPs, such as the entire family of mammalian MAPs, the EMAP-like (EML) 
proteins. EMAPs had initially been discovered as main components of the microtubule 
cytoskeleton in sea urchin eggs [35, 36], and the human homologs of these proteins were 
found based on sequence similarities [37, 38]. The fact that the EMAP family has six 
members in mammals strongly suggests important functions, however so far, little is known.  
Another technological advance - cDNA libraries - allowed the setup of screens to identify 
novel MAPs based on their localization to microtubules in cells. This allowed for the 
identification of epithelial MAP of 115 kDa (E-MAP-115, later named MAP7) [17], GLFND 
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[39], and MTR120 (MAP10) [40]. Even screens designed for other purposes could reveal the 
association of novel proteins with microtubules. For instance, MAP8 was initially discovered 
as an interaction partner of a protein related to male infertility [41]. Because of its homology 
to MAP1A/B proteins, MAP8 was also referred to as MAP1S [42]. MAP9, also known as 
ASAP (Aster-associated protein) was discovered in a screen for proteins involved in 
intracellular trafficking [43]. Using genome-wide linkage analysis and whole-exome 
sequencing, mutations of the gene C7orf43 were linked to cases of human microcephaly. 
C7orf43 encodes a protein that binds microtubules in cells, and was hence named MAP11 
[44]. Figure 1 summarizes the timeline of MAPs discovery (Fig. 1). 
Finally, advances in proteomics now allow for a more complete identification of proteins that 
co-purify with microtubules, for instance from Xenopus laevis egg extracts [45]. However, 
thorough biochemical characterization of newly identified proteins remains an essential 
prerequisite before validating them as bona fide MAPs (Box 1).  
 
The role of MAPs in structuring the microtubule cytoskeleton 
Since their discovery in the early 1970s, it was clear that MAPs can promote microtubule 
polymerization, stabilisation and bundling in vitro [10, 46, 47]. When overexpressed in 
mammalian cells, all MAPs decorated the microtubule cytoskeleton, however only some of 
them, such as tau, induced microtubule bundling [48, 49]. There have been different 
hypotheses on how MAPs directly participate in microtubule bundling. MAPs could create a 
direct physical connection between neighbouring microtubules [50], or alternatively, the 
stabilisation of microtubules alone could be sufficient to induce bundling [51]. Early studies 
with the microtubule-stabilising drugs Taxol, or the nonhydrolyzable analogue of GTP, 
GMPCPP, had already suggested that suppression of microtubule dynamics might be 
sufficient for the formation of microtubule bundles (discussed in [51]). Indeed, the same 
appears to be true for MAPs: expression of a minimal microtubule-binding domain of tau, for 
instance, was sufficient to induce microtubule bundling in vitro [52]. A mechanism by which 
a minimal MAP domain could promote microtubule bundling was recently proposed based on 
structural data: upon binding, the positively charged amino-acid patches typically present in 
MAPs would neutralize the high negative charge of carboxy-terminal tails of tubulins, thus 
reducing electrostatic repulsion between microtubules, thus allowing spontaneous bundling 
[53]. A strong argument in favour of this hypothesis is that removal of the negatively charged 
tubulin tails by subtilisin alone induces microtubule bundling [54].  
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It thus appears that regions of MAPs that do not directly interact with microtubules do not 
participate in the microtubule bundling. On the contrary, they might even prevent it by 
pushing microtubules apart from each other. For example, overexpressed full-length MAP4, 
which has a long projection domain (Fig. 2), binds microtubules without inducing their 
bundling [48, 55], while the MAP4 microtubule-binding domain alone does induce bundling 
[56]. This essentially leads back to some of the initial observations in vitro [13] and in vivo 
[57, 58], which showed that microtubule spacing is regulated by the size of the projection 
domains of different MAPs, and therefore, longer projection domains would prevent bundling 
by keeping microtubules apart (Fig. 3A). In this light, the fact that several MAPs express 
isoforms with projection domains of variable length [30, 33, 59] suggests a regulatory 
mechanism for microtubule network organization. At the same time, the extended projection 
domains could also serve as interaction platforms for other proteins, discussed below.  
Notwithstanding the mechanisms involved, presence of MAPs reduces microtubule 
depolymerization frequency as apparent from longer microtubule life times in the presence of 
depolymerizing drugs [49, 60], or from accumulation of posttranslational modifications on 
MAP-stabilized microtubules [61]. However, how this stabilization is achieved on the 
molecular level has for a long time remained difficult to decipher due to the absence of 
structural data, which is mainly attributed to the disordered structure of many MAPs.  
Most MAPs do not adapt a defined structure in solution and were thus generally considered to 
be disordered proteins. Recently, advances in cryo-electron microscopy have allowed to 
directly visualize how MAPs bind to microtubules [62]. The protein tau forms an extended 
structure that binds the microtubule surface along a protofilament, thereby spanning both 
intra-and inter-dimer tubulin interfaces and interacting with three tubulin monomers [63]. 
Strikingly, tau was found adjacent to the unstructured C-terminal tails of tubulin, thus 
underpinning the potential importance of these tails [64] and their posttranslational 
modifications [65] in controlling the tau-microtubule interactions. 
It is highly likely that high-resolution structures of other MAPs will follow soon [66], 
allowing us to understand their functions from a novel, structural perspective. Similarities of 
the microtubule-binding domains of several MAPs, such as tau, MAP2 and MAP4 will 
certainly reflect the way these MAPs bind to microtubules.  
A large number of MAPs can potentially coexist on a microtubule and a number of different 
MAP binding sites exist on the microtubule surface. For example, doublecortin (DCX), a 
MAP particularly abundant in neurons during development, binds microtubules on a different 
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site than tau. The DCX binding site is found between adjacent protofilaments, thus allowing 
this MAP to connect four tubulin molecules, which both strengthens and determines the inter-
protofilament and tubulin-dimer interactions. As a result, DCX forces microtubules into a 13-
protofilament configuration (Fig. 3E) [67].  
In the light of the emerging structural biology of MAPs, it is important to remember that 
MAPs are not merely a ‘glue’ that sticks to the microtubule surface thereby preventing 
depolymerization, but rather dynamically bind and unbind microtubules as recently shown for 
tau [68]. Current work even suggests that tau protein does not stabilize microtubules, but 
rather allows some of them to remain labile in axons [69, 70]. This echoes earlier 
observations for MAP1B, which suggested that this protein actually regulates the dynamic 
fraction of microtubules [71, 72].  
 
MAPs as crosslinkers of different cytoskeletal components 
Apart from the 25-nm microtubules, eukaryotic cells contain two other principal cytoskeletal 
fibre networks: 4-nm actin filaments, and ~10-nm intermediate filaments. The interaction of 
these different cytoskeletal elements is essential for a range of cellular functions, such as 
directional cell migration [73], or neuronal pathfinding [74]. Today we know a number of 
MAPs able to connect microtubules to actin and/or intermediate filaments, which are 
therefore referred to as cytoskeletal crosslinkers (Fig. 3D).  
Two major cytoskeletal crosslinkers are the microtubule-actin crosslinking factors 1 and 2 
(MACF1, MACF2). MACF1 was initially discovered as actin crosslinking factor 7 (ACF7) 
[75], and MACF2 as bullous pemphagoid antigen 1 (BPAG1) [76], or dystonin (DST) [77]. 
Both proteins are bona fide crosslinkers of the microtubule and actin cytoskeletons [78, 79], 
but they also interact with intermediate filaments [80, 81]. The striking feature of MACF 
proteins is their large size (MACF1 ~600 kDa, MACF2 ~900 kDa), and both proteins contain 
amino-terminal actin- and carboxy-terminal microtubule-binding domains, separated by very 
long spectrin repeat domains that provide physical spacers between the actin and microtubule 
networks. The dominant localization cue for MACF proteins appears to be the microtubule 
network [79], which is why these proteins could primarily be considered as MAPs [82]. 
Dystrophin, another protein consisting extended spectrin repeats, had initially been described 
as an actin-binding proteins [83], and only the recent discovery that it can bind microtubules 
in the muscle cells now qualifies dystrophin as cytoskeletal crosslinker [84]. 
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To be able to study the actin-microtubule crosslinking mechanism of MACF1 in vitro, a short 
version of the protein, called TipAct, was prepared by excluding its long central spectrin 
domain (Fig. 2), thus encompassing only the amino-terminal actin- and the carboxy-terminal 
microtubule-binding domains. TipAct tracks microtubule plus-ends in an EB-protein-
dependent manner, and links them to actin filaments, thus guiding microtubule growth along 
actin bundles [85].  
With their ability to bind three cytoskeletal elements, MACF proteins can participate in a 
large variety of cellular functions. MACF1 plays a key role in cell migration, thus controlling 
wound healing [86, 87], neuronal migration during brain development [88, 89], as well as 
dendritic arborisation and axon outgrowth [90, 91]. MACF2 is essential for the correct 
alignment of microtubules and intermediate neurofilaments in large-calibre sensory neurons, 
which in MACF2-knockout mice are hugely disorganized. This cytoskeletal disorganisation is 
accompanied by organelle accumulations that reveal defects in axonal transport [80, 92]. 
Moreover, mutations in MACF2 lead to dystonia musculorum in mice [77] and humans [93]. 
Alternative splicing of MACF1 and MACF2 can generate variants of the proteins with 
different domain composition, which can alter their molecular roles in connecting the 
different cytoskeletal networks. Strikingly, different splice isoforms give rise to distinct 
biological roles of the proteins, and are also linked to specific pathologies (reviewed in ref. 
[94-96]) 
The clear distinction of actin-, intermediate-filament- and microtubule-binding motifs of 
MACFs makes these proteins prime example of cytoskeletal linkers. Nevertheless, other 
MAPs have also been implicated in the binding of multiple cytoskeletal components, though 
their most-studied function relates to their microtubule binding. All members of the MAP1 
family, MAP1A, MAP1B and MAP1S, have been shown to interact with actin as well as with 
microtubules [42, 97-99], with the actin- and microtubule-binding sites clearly separated 
within the primary sequence of these proteins. It is thus conceivable that these MAPs can 
serve as cytoskeletal linker proteins and this notion is supported by the observation that 
MAP1B-deficient neurons display decreased activity of the actin regulators Rac1 and Cdc42 
[100].  
Finally, a number of reports suggest that other MAPs also interact with different cytoskeletal 
networks, however the physiological relevance of these mostly biochemically determined 
interactions still needs to be elucidated (Box 2). 
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Physiological functions of MAPs 
MAPs help cells in organising the microtubule cytoskeleton (Fig. 3). However, how MAP-
induced changes in the cytoskeleton alter the physiological processes is just beginning to be 
understood. One of the key reasons for this lack of insight is that exogenous expression of 
MAPs, which was for decades the only way of introducing them into mammalian cells, leads 
to a variety of artefacts that are most frequently related to an overstabilisation of 
microtubules. Given that the regulation of microtubule dynamics by stabilisation or 
destabilisation with MAPs is a highly concentration-dependent biophysical process, any kind 
of non-physiological expression level can henceforth be artificial. It will thus be key to use 
gene-targeting approaches to directly label endogenous MAPs to observe their functions at 
physiological levels.  
Still, several insights into cellular functions of MAPs have been gained by overexpression 
approaches, especially for tau, which is particularly well-explored due to its key role in 
neurodegenerative disorders (for a detailed review, see [101]). Tau was implicated in 
intracellular traffic control, as its overexpression [102] and hyperphosphorylation impede 
transport of synaptic vesicles and organelles in vivo [103, 104]. Strikingly, reduction of tau 
levels could rescue axonal transport defects observed in mouse models for Alzheimer’s 
disease [105]. It will be important to understand if these effects are due to changes in the 
structural organisation of the microtubule cytoskeleton, i.e. an alteration in the spacing of 
axonal microtubules [57, 106], or due to a direct regulation of the transport processes by tau 
protein, as suggested by in vitro reconstitutions of transport in the presence of tau [107, 108].  
In a similar manner, other MAPs such as MAP1B [109], MAP2, MAP4 [110, 111], MAP6 
[112] and MAP7 [113-116] were shown to influence intracellular transport but perhaps not 
with the same selectivity (Fig. 3F). Indeed, MAP2, a neuronal MAP that is excluded from 
axons in differentiated neurons, controls cargo sorting at pre-axonal filtering zone by 
distinguishing KIF1- from KIF5-dependent cargoes [117]. MAP4 showed a specific inhibition 
of dynein-driven movements in Xenopus laevis melanocytes, whereas it activated kinesin-2-
driven transport in these cells [111].  
MAPs can also regulate microtubule dynamics by controlling the activity of microtubule-
severing enzymes. For instance, MAP4 from Xenopus laevis can inhibit katanin-mediated 
microtubule severing in vitro [118], and tau, MAP2 and MAP4 can protect microtubules 
against severing by overexpressed katanin in mammalian cells (Fig. 3C) [119]. 
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On the mechanistic side, MAPs might physically impede motors or severing enzymes to 
interact with microtubules in regions densely decorated with MAPs. The recently discovered 
tau islands that stall kinesin motility provide a first model for a mechanism that could 
potentially shield microtubule stretches in cells [120, 121]. However, there are multiple other 
mechanisms by which MAPs could influence the function of the microtubule cytoskeleton. 
Members of the MAP7 family for example directly regulate the motor activity of kinesin-1 
[115, 122].  
MAPs can also control each other. A number of MAPs interact with microtubules at similar 
sites, and could thus compete for microtubule binding. This has been so far demonstrated for 
MAP7, which is able to displace tau protein from microtubules in vitro [113]. The 
competition between tau and MAP7 might play an important role in the determination of 
neuronal connectivity, as both MAPs are distinctly involved in formation of axonal branches 
[123, 124]. These exciting discoveries provide first glimpses at the potentially large variety of 
regulatory roles of MAPs. 
In general, MAPs interact with a plethora of proteins and might thus link the microtubule 
cytoskeleton to many other cellular functions, such as signal transduction pathways and 
synaptic functions [125]. For instance, MAP1A/B that interact with postsynaptic density 
proteins and several ligand-gated ion channels or transmembrane receptors [99, 126], thus 
controlling synaptic functions. MAP2 associates with a number of protein kinases such as 
cAMP-dependent protein kinase (PKA) and its regulatory subunit [127], or the tyrosine 
protein kinases Src and Fyn [128, 129], thus sorting these signalling proteins into the somato-
dendritic compartment of neurons [127, 130]. The close link between neuronal, and in 
particular synaptic signal-transduction machineries and MAPs opens the exciting possibility 
that neuronal activity could be directly propagated to the microtubule cytoskeleton, and thus 
regulate its function. Indeed, recent work shows that MACF1 associates with acetylcholine 
receptors (AChRs) at the neuromuscular synapses and controls the efficiency of signal 
transmission in mice [131].  
MAPs can further interact with membranes, but so far only a few examples are known. The 
protein tau localizes to the inner side of the plasma membrane [132], which might either 
titrate this MAP away from the microtubules, or connect microtubules to the plasma 
membrane (Fig. 3B). MACF1 also associates with the membrane of Golgi vesicles, thus 
mediating their transport from the trans-Golgi network to the cell periphery [133]. Moreover, 
the finding that MAP1B regulates the degradation of Rab35 [134] suggests a role in 
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membrane trafficking in neurons. It is highly likely that other MAPs also interact with cellular 
membranes, potentially playing a key role in intracellular integration. Last but not least, 
MAPs can facilitate viral infections by serving as adapters between the viral particles and the 
microtubule tracks, on which the virus is transported into the cell nucleus [135]. 
The multiple interactions of MAPs with functionally important cellular machineries clearly 
point towards their essential roles in coordinating cytoskeletal functions with a variety of 
physiological processes. The large size of many MAPs predestines them to be scaffold 
proteins for entire machineries working on the microtubules, such as transport and signalling 
complexes. Strikingly, these complexes might even contain tubulin-modifying enzymes [72], 
thus allowing MAPs to directly regulate the tracks to which they bind.  
 
Implications of MAPs in pathologies 
Given the large number of functions performed by MAPs, it is not surprising that they are 
also involved in various pathological conditions (reviewed in [136]). Transgenic mice for 
mutant/missing MAPs have underpinned their importance in maintaining structure and 
functions of the mammalian brain. For example, mice lacking tau display age-onset 
neurodegeneration [137]. MAP2- or MAP1B-knockout mice show neurodevelopmental 
defects [100, 130, 138-140], and mice with disrupted MAP1A gene display Purkinje-cell 
degeneration [141]. The MAP6-knockout mouse is recognised as a model of schizophrenia 
[142, 143]. Strikingly, in all these cases, it is not the pathological accumulation of the MAPs, 
but their deficiency that leads to the pathology. This underpins their importance in cellular 
homeostasis, and points toward the possibility that changes in the balance of MAP-
microtubule interactions are sufficient to induce pathological events that lead to neuronal 
disorders.  
This perspective opens up novel prospects for alternative molecular pathways in MAP-related 
disorders. For example, Alzheimer’s and Parkinson’s disease, as well as frontotemporal 
dementia and other tauopathies are characterized by the prevalent pathological hallmark of 
aggregated tau protein [34, 144, 145], and research has focussed on tau aggregation as the key 
event in their pathogenesis. However, it is likely that the initial events are rather early 
perturbations of the physiological functions of MAPs. Moreover, these initial events could be 
also regulated by the tubulin posttranslational modifications, proposed to control MAP-
microtubule interactions. For example, recent findings demonstrating that abnormally 
increased microtubule polyglutamylation leads to neurodegeneration in a variety of neuronal 
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cell types in mouse, as well as in a newly discovered human disorder strongly underpin this 
notion [146, 147].  
 
Concluding remarks and future directions: the emerging roles of MAPs 
In this review, we have discussed how ‘structural MAPs’ fulfil different functions on the 
microtubule cytoskeleton, beyond their common characteristics – the binding to microtubules. 
MAPs can regulate microtubule dynamics and organization of microtubules, but also 
interactions of microtubules with other functionally important proteins such as molecular 
motors or regulators of microtubule stability. MAPs further link microtubules to other 
cytoskeletal elements, non-cytoskeletal proteins and protein complexes, or membrane 
compartments in cells.  
Little is known so far about the regulation of local MAP concentrations in cells, which will be 
one of the crucial questions to answer if the patterning of the microtubule cytoskeleton with 
MAPs is to be understood. MAPs could recognize specific microtubule configurations, such 
as parallel or anti-parallel arrays (Fig. 3G). This is well-studied for the proteins TRIM46, a 
MAP that assembles plus-end-out microtubule arrays in the axon initial segment [148], and 
PRC1, which accumulates specifically at antiparallel overlapping microtubules at the mitotic 
spindle midzone [149, 150]. Another potential regulatory mechanism for MAP localisation 
could be the tubulin code, i.e. specific tubulin isotypes or posttranslational modifications of 
microtubules [151], which could attract MAPs to distinct microtubule arrays in cells. In 
addition, MAPs themselves are posttranslationally modified [6], and might be able to control 
the posttranslational modifications of the microtubules they bind to [72]. A complex 
regulatory network coupling the tubulin code to a hypothetical MAP code could thus create a 
broad variety of microtubule identities that coordinate cytoskeletal functions in cells. Indeed, 
different MAPs show distinct subcellular localisations in neurons, which correlates with their 
specific contributions to a variety of neuronal functions [136].  
Finally, the concentration of MAPs can be drastically increased by phase transitions. In this 
process, a protein separates from the surrounding cytosol into a liquid phase droplet of which 
it is the sole constituent [152]. Droplets of the protein tau could serve as microtubule 
nucleation centres due to the extraordinarily high concentration of the MAP, which could 
enrich tubulin above the critical concentration needed for its polymerization [153]. It is 
tempting to imagine that reversible phase separation takes place on the microtubules, with the 
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more tempting possibility that local concentrations needed to initiate phase transition of 
MAPs are induced by locally enriched tubulin modifications (Fig. 4).  
Another emerging concept is that MAPs can impact the molecular structure of microtubules. 
It has already been shown that DCX can determine the precise number of protofilaments (Fig. 
3E) [67], which might explain why in cells microtubules have a much more controlled 
protofilament number than in-vitro assembled microtubules [154]. Moreover, recent findings 
suggest that MAPs can generate a whole range of ‘unusual’ microtubule structures. For 
example, the protein SSNA1 (a.k.a. NA14), which stabilises single-protofilament protrusions, 
can generate microtubule branches [155]. Mechanisms of protofilament stabilisation might 
also allow for the maintenance of damaged microtubules until they are repaired by re-
incorporation of tubulin dimers (Fig. 4) [156]. Such mechanisms could be rather common in 
cells, and many MAPs might have such activities depending on their local concentrations 
[157]. The control of microtubule damage and repair has recently gained an even greater 
dimension with the discovery that motor proteins damage the microtubule tracks they walk on 
[158, 159]. Lattice maintenance might thus be one of the previously neglected cellular 
functions of MAPs. Moreover, MAPs that bind to the luminal side of microtubules, the so-
called microtubule-inner proteins (MIPs), have only recently come into focus [160], and 
provide novel options for the regulation of microtubule dynamics and structure [161]. Last, 
but certainly not least, there is an emerging family of proteins that bind to tubulin dimers, 
called tubulin-associated proteins (TAPs) [162]. While some TAPs might just be MAPs able 
to interact with soluble tubulin dimers, others could bind exclusively to unpolymerized 
tubulin dimers, and have a strong impact on microtubule homeostasis in cells, as it was 
demonstrated for the tubulin-sequestering protein stathmin [163].  
In the light of those emerging mechanisms it appears that the name ‘structural MAPs’, which 
had been coined for a vaguely defined family of proteins whose only common characteristics 
is that they bind to microtubules, has gained a greater mechanistic dimension: many of the 
here-discussed MAPs, and others yet to be identified, might turn out to be the key 
determinants of cytoskeletal architecture.  
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Outstanding questions 
• Does the abundance of MAPs in a cell really reflect their biological importance? What 
are the functions of less abundant MAPs? 
• What could be a novel definition of a MAP, and which experiments/approaches could be 
used to validate a protein as bona fide MAP?  
• How do different MAPs function in a single cell? Do they all have distinct or redundant 
functions, or do they compete with each other? 
• How are local MAP concentrations controlled in cells, and how does this contribute to 
the patterning of the microtubule cytoskeleton? 
• How does the tubulin code, i.e. tubulin isotypes and their posttranslational modifications, 
control MAP binding to functionally specific microtubules? To what extent do MAPs 
influence the tubulin code? 
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Figures and Boxes 
Box 1: Redefining MAPs 
Over the years, proteins were discovered to interact with microtubules by various assays. 
However, there are a number of difficulties in designing functional experiments to test newly 
identified proteins for validating their potential role as MAPs. An important question is thus 
how to define novel proteins as bona-fide MAPs. The early definition of a MAP was that “it 
copolymerizes with tubulin through repeated cycles of microtubule assembly in vitro; it is not 
associated with any brain subcellular fraction other than microtubules; in double-label 
immunofluorescence experiments antibodies against this protein stain the same fibrous 
elements in cultured cells as are stained by anti-tubulin; and this fibrous staining pattern is 
dispersed when cytoplasmic microtubules are disrupted by colchicine.” [24]. While this 
definition is somewhat still valid, it might need some refinement to consider potential 
artefacts, for instance that overexpression of some proteins can force them into non-
physiological microtubule decoration or that overexpression of these MAPs could favour low-
affinity interactions. Therefore, thorough biochemical characterization of newly identified 
proteins is still an essential prerequisite before considering them MAPs. 
 
Box 2: Potentially more cytoskeletal crosslinker MAPs? 
Several MAPs including MAP2 [164], MAP4 [165], or tau protein [166] have been 
demonstrated to bind actin. However, the actin-binding domains of MAP2, MAP4 and tau 
protein have been mapped to the very microtubule binding regions of these proteins [165, 
166]. In the case of MAP2 for instance, actin binding is only possible in the absence of 
tubulin [164], which appears to preclude this MAP from acting as a cytoskeletal crosslinker. 
Thus, under physiological conditions, an association of those MAPs with the actin 
cytoskeleton might only happen in cellular compartments with low microtubule content, such 
as filopodia or leading edges of migrating cells. Strikingly, a recent reconstruction of 
microtubule and actin networks in vitro has clearly shown that tau protein can connect these 
two networks with its microtubule-binding repeats. It appears that tau binds to microtubules 
with at least one of its microtubule-binding repeat, and connects to actin with another of these 
repeats [167]. Considering that several MAPs, such as MAP2 and MAP4, have similar 
microtubule-binding repeats, this study provides a new model how MAPs could link 
microtubule and actin networks only with their microtubule-binding domains. 
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A number of MAPs can also interact with intermediate filaments. MAP2 can localize to 
vimentin in cells, which suggested that it could coordinate intermediate filaments and 
microtubule networks [168, 169]. The protein tau has equally been reported to bind vimentin 
intermediate filaments [170], however, no further functional studies on the role of MAPs in 
intermediate filament organization and crosstalk with microtubules have been performed. 
Finally, MAP4 was demonstrated to interact with septins [171], another filamentous network 
important for a range of cellular functions [172].  
Thus, many MAPs have been shown to bind to different cytoskeleton networks, and were thus 
suggested to act as cytoskeletal crosslinkers. The physiological relevance of these findings, 
however, remains to be explored. 
 
Figure 1: Timeline of the discovery of mammalian MAPs, and their dependency on the 
development and availability of experimental approaches. The timeline starts with the first 
ultrastructural description of microtubules [173], and the identification of their protein 
building block tubulin [174]. 
 
Figure 2: Schematic representation of MAPs scaled to their relative sizes. The approximate 
localisation of different cytoskeleton-interacting domains is shown (no precise domain 
boundaries are given due to different representations in the literature). Domain information 
were obtained from the following references: MACF1, MACF2 [95, 175], MAP1A, MAP1B, 
MAP8/MAP1S [6, 136], MAP2, MAP4, Tau, MAP6 [136], MAP7, MAP7D1, MAP7D2, 
MAP7D3 [115], MAP9 [136], MAP10 [40], EML1, EML2, EML3, EML4, EML5, EML6 
[176, 177], DCX [6]. The longest annotated human isoforms of each MAP are depicted: 
MACF1 (XM_006710540), MACF2 (XM_005249315), MAP1A (XM_017022189), MAP1B 
(NM_005909), MAP8/MAP1S (NM_018174), MAP2 (NM_002374), MAP4 (NM_002375), 
Tau (NM_005910), MAP6 (NM_033063), MAP7 (NM_001198609), MAP7D1 (BC106053), 
MAP7D2 (BC136379), MAP7D3 (XM_024452448), MAP9 (AY690636), MAP10 
(AB037804), MAP11 (NM_018275), EML1 (NM_004434), EML2 (NM_012155),EML3 
(NM_153265), EML4 (NM_019063), EML5 (NM_183387), EML6 (NM_001039753) and 
DCX (NM_000555). 
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Figure 3: Schematic representation of the different ways MAPs can bind to microtubules, and 
how these modes of binding influences microtubule structure, behaviour, and functions: (A) 
binding and spacing microtubules with long MAP projection domains, (B) connecting 
microtubules to membranes, (C) protecting microtubules from severing enzymes, and thus, 
from disassembly, (D) crosslinking different cytoskeletal elements, (E) controlling the 
protofilament numbers of microtubules, (F) affecting the binding and motility of motor 
proteins by either forming a complex with the motor, or by occupying the motor path at the 
microtubule surface, (G) promoting microtubule bundling, by neutralising acidic tubulin 
carboxy-terminal tails.  
 
Figure 4: Schematic representation of some emerging mechanisms of MAPs. Depending on 
their concentration at the microtubules surface, MAPs can form condensates (islands) or 
undergo phase transition to form liquid droplets. Some MAPs can bind incomplete 
microtubules, or single protofilaments, thus stabilising such structures, and eventually 
allowing microtubule repair, or branching. Posttranslational modifications of tubulin could 
regulate the binding parameters of MAP, thus controlling MAP functions. Vice versa, MAPs 
might be implicated in controlling microtubule modifications.  
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